New pill aims to ease sickle cell anemia without pain crises
Disease control
Not yet recruiting
This study tests a drug called SIL-8301 (senicapoc) in 105 adults with sickle cell disease who have low hemoglobin but few pain crises. Participants take the drug or a placebo daily for 24 weeks, along with their usual hydroxyurea. The main goal is to see if the drug raises hemog…
Phase: PHASE2 • Sponsor: Biossil Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC